UnknownPhase 4

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

Indonesia1,000 participantsStarted 2018-03-31

Plain-language summary

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing transradial catheterisation using proximal radial artery puncture technique Exclusion Criteria: * Blood pressure \<100 mmHg * Refuse to participate

What they're measuring

The incidence of Moderate to severe radial artery spasm

Timeframe: During the index procedure

Trial details

NCT IDNCT03889470

SponsorHermina Heart Center Kemayoran

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-30

Contact for this trial

Agnes Intan, MD

622122608047 agnesintan1231@gmail.com

View on ClinicalTrials.gov More Radial Artery Injury trials